South Carolina is Just Right for Bioscience PDF Download
Are you looking for read ebook online? Search for your book and save it on your Kindle device, PC, phones or tablets. Download South Carolina is Just Right for Bioscience PDF full book. Access full book title South Carolina is Just Right for Bioscience by . Download full books in PDF and EPUB format.
Author: Publisher: ISBN: Category : Biotechnology industries Languages : en Pages : 2
Book Description
Recent investments by leading pharmaceutical and biotechnology companies is bringing recognition to South Carolina as a top destination for the life sciences industry. With a talented and innovative workforce, top research institutions, and world-class hospital systems, South Carolina is ready to support a thriving life sciences industry.
Author: Publisher: ISBN: Category : Biotechnology industries Languages : en Pages : 2
Book Description
Recent investments by leading pharmaceutical and biotechnology companies is bringing recognition to South Carolina as a top destination for the life sciences industry. With a talented and innovative workforce, top research institutions, and world-class hospital systems, South Carolina is ready to support a thriving life sciences industry.
Author: Publisher: ISBN: Category : Biotechnology industries Languages : en Pages : 2
Book Description
Recent investments by leading pharmaceutical and biotechnology companies is bringing recognition to South Carolina as a top destination for the life sciences industry. With a talented and innovative workforce, top research institutions, and world-class hospital systems, South Carolina is ready to support a thriving life sciences industry.
Author: South Carolina Commission on Higher Education. Consultant Team for the Life Sciences Publisher: ISBN: Category : Biology Languages : en Pages : 168
Author: Eric J. Vettel Publisher: University of Pennsylvania Press ISBN: 0812203623 Category : History Languages : en Pages : 291
Book Description
The seemingly unlimited reach of powerful biotechnologies and the attendant growth of the multibillion-dollar industry have raised difficult questions about the scientific discoveries, political assumptions, and cultural patterns that gave rise to for-profit biological research. Given such extraordinary stakes, a history of the commercial biotechnology industry must inquire far beyond the predictable attention to scientists, discovery, and corporate sales. It must pursue how something so complex as the biotechnology industry was born, poised to become both a vanguard for contemporary world capitalism and a focal point for polemic ethical debate. In Biotech, Eric J. Vettel chronicles the story behind genetic engineering, recombinant DNA, cloning, and stem-cell research. It is a story about the meteoric rise of government support for scientific research during the Cold War, about activists and student protesters in the Vietnam era pressing for a new purpose in science, about politicians creating policy that alters the course of science, and also about the release of powerful entrepreneurial energies in universities and in venture capital that few realized existed. Most of all, it is a story about people—not just biologists but also followers and opponents who knew nothing about the biological sciences yet cared deeply about how biological research was done and how the resulting knowledge was used. Vettel weaves together these stories to illustrate how the biotechnology industry was born in the San Francisco Bay area, examining the anomalies, ironies, and paradoxes that contributed to its rise. Culled from oral histories, university records, and private corporate archives, including Cetus, the world's first biotechnology company, this compelling history shows how a cultural and political revolution in the 1960s resulted in a new scientific order: the practical application of biological knowledge supported by private investors expecting profitable returns eclipsed basic research supported by government agencies.
Author: Nichola Lowe Publisher: MIT Press ISBN: 0262547910 Category : Business & Economics Languages : en Pages : 197
Book Description
An argument for reimagining skill in a way that can extend economic opportunity to workers at the bottom of the labor market. The United States has a jobs problem—not enough well-paying jobs to go around and not enough clear pathways leading to them. Skill development is critical for addressing this employment crisis, but there are many unresolved questions about who has skill, how it is attained, and whose responsibility it is to build skills over time. In this book, Nichola Lowe tells the stories of pioneering workforce intermediaries—nonprofits, unions, community colleges—that harness this ambiguity around skill to extend economic opportunity to workers at the bottom of the labor market. Skill development confers shared value to both workers and employers because it lies at the intersection of their respective interests. Connecting skill to economic inequality, Lowe calls for solutions that push employers to accept greater responsibility for skill development. She examines real-world examples of workplace intermediaries throughout the United States, exploring in detail the work of manufacturing-focused organizations in Chicago and Milwaukee, and a network of community colleges in North Carolina that coordinates training for biopharmaceutical manufacturers. As workforce intermediaries help employers reinterpret skill, they also convince them to implement inclusive work-based systems that extend family-sustaining wages and better working conditions across the entire workforce. With renewed policy emphasis on skill development, these opportunity-rich solutions can be further expanded—ensuring workers across the entire educational spectrum contribute skills that drive innovation forward and share the gains they generate for the twenty-first century workplace.
Author: National Research Council Publisher: National Academies Press ISBN: 0309287340 Category : Political Science Languages : en Pages : 257
Book Description
Most of the policy discussion about stimulating innovation has focused on the federal level. This study focuses on the significant activity at the state level, with the goal of improving the public's understanding of key policy strategies and exemplary practices. Based on a series of workshops and conferences that brought together policymakers along with leaders of industry and academia in a select number of states, the study highlights a rich variety of policy initiatives underway at the state and regional level to foster knowledge based growth and employment. Perhaps what distinguishes this effort at the state level is most of all the high degree of pragmatism. Operating out of necessity, innovation policies at the state level often involve taking advantage of existing resources and recombining them in new ways, forging innovative partnerships among universities, industry and government organizations, growing the skill base, and investing in the infrastructure to develop new technologies and new industries. Many of these initiatives are being guided by leaders from the private sector and universities. The objective of Best Practices in State and Regional Innovation Initiatives: Competing in the 21st Century is not to do an empirical review of the inputs and outputs of various state programs. Nor is it to evaluate which programs are superior. Indeed, some of the notable successes, such as the Albany nanotechnology cluster, represent a leap of leadership, investment, and sustained commitment that has had remarkable results in an industry that is actively pursued by many countries. The study's goal is to illustrate the approaches taken by a variety of highly diverse states as they confront the increasing challenges of global competition for the industries and jobs of today and tomorrow.
Author: Richard Barker Publisher: Oxford University Press ISBN: 0191057681 Category : Medical Languages : en Pages : 241
Book Description
Medical innovation as it stands today is fundamentally unsustainable. There is a widening gap between what biomedical research promises and the impact that it is currently achieving, in terms of patient benefit and health system improvement. This book highlights the global problem of the ineffective translation of bioscience innovation into health system improvements and its consequences, analyses the underlying causative factors and provides powerful prescriptions for change to close the gap. It contrasts the progress in biomedicine with other areas of scientific and technological endeavour, such as information technology, in which there are faster and more reliable returns for society. The author's career has spanned pharmaceuticals, diagnostics and health informatics and he draws lessons from a host of case examples in which bottlenecks have prevented progress, such as in dementia and antibiotic-resistant infections, and from many in which these barriers have been overcome, such as HIV therapy and targeted cancer treatment. The new era of precision medicine holds the greatest promise of closing this 'innovation gap'. Along with techniques such as open innovation and adaptive development, powerful new genomics and digital health tools are poised to transform the productivity of life sciences. Bioscience-Lost in Translation? lays out a fresh and provocative strategy for advancing the innovation process, shaping the right policy environment and building an ecosystem to deliver the 21st century cures that are urgently needed.
Author: 
Author: 
Author: 
Author: 
Author: South Carolina Commission on Higher Education. Consultant Team for the Life Sciences
Author: Eric J. Vettel
Author: Nichola Lowe
Author: National Research Council
Author: 
Author: Richard Barker
Author: University of Minnesota (Minneapolis-St. Paul campus)